5 research outputs found
沃度保兒謨ニ因セル濕疹
Evaluation of CNA-IC50 correlations by known cancer driver mutations. Distributions of PCCs for cancer cell lines with mutated or wild-type proto-oncogenes or tumor suppressors as depicted in each figure. The rank position of negatively correlated drugs (p < 0.10) is shown. (EPS 975 kb
Sequence alignments, clones analyzed and constraints applied
Sequence alignments, clones analyzed and constraints applie
Additional file 5: Figure S3. of Cancer network activity associated with therapeutic response and synergism
The CNA-IC50 correlation differences are not observed when a random, null network model that preserves degree distribution and connectedness is analyzed. (PDF 148 kb
Additional file 8: Table S4. of Cancer network activity associated with therapeutic response and synergism
Correlations of drug target gene expression and CNA values. (XLSX 42 kb
Additional file 2: Table S2. of Cancer network activity associated with therapeutic response and synergism
Normalized CNA values for all cancer cell lines. (XLSX 55 kb